Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

EWTX

Edgewise Therapeutics Inc

May 29 • 04:00PM ET

34.16

+0.86 2.58 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: KYMR RYTM VKTX APGE NUVL BMRN MDGL KRYS AXSM NBIX

| Held by: VTI IWM VXF IBB IWO SCHA VTWO DFMC FESM XPH

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.66	Insider Own	27.07%	Shs Outstand	107.48M	Perf Week	4.50%
Market Cap	3.68B	Forward P/E	-	EPS next Y	-2.28	Insider Trans	-0.81%	Shs Float	78.46M	Perf Month	12.18%
Enterprise Value	3.18B	PEG	-	EPS next Q	-0.49	Inst Own	86.23%	Short Float	13.20%	Perf Quarter	12.22%
Income	-176.01M	P/S	-	EPS this Y	-26.08%	Inst Trans	-4.14%	Short Ratio	9.89	Perf Half Y	41.98%
Sales	0.00M	P/B	7.44	EPS next Y	-11.03%	ROA	-36.18%	Short Interest	10.35M	Perf YTD	37.66%
Book/sh	4.59	P/C	7.36	EPS next 5Y	-1.47%	ROE	-38.14%	52W High	39.96 -14.51%	Perf Year	134.45%
Cash/sh	4.64	P/FCF	-	EPS past 3/5Y	-8.91% -36.19%	ROIC	-35.49%	52W Low	12.15 181.15%	Perf 3Y	240.58%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	4.50% 4.70%	Perf 5Y	18.32%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-7.28%	Oper. Margin	-	ATR (14)	1.65	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	22.61	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	55.67	Recom	1.33
Dividend Gr. 3/5Y	- -	Current Ratio	22.61	EPS Q/Q	-6.69%	SMA20	1.47%	Beta	0.27	Target Price	43.67
Payout	-	Debt/Eq	0.01	Sales Q/Q	-	SMA50	4.60%	Rel Volume	1.09	Prev Close	33.30
Employees	146	LT Debt/Eq	0.01	Earnings	May 07 BMO	SMA200	39.42%	Avg Volume	1.05M	Price	34.16
IPO	Mar 26, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	5.08% -	Trades		Volume	1,144,914	Change	2.58%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)